These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 36998672)
1. The " Guo Q; Peng L; Rao L; Ma C; Zhao K; Zhao Z; Tang H; Li M J Interv Cardiol; 2023; 2023():6889836. PubMed ID: 36998672 [TBL] [Abstract][Full Text] [Related]
2. Comparison of angiographic change in side-branch ostium after drug-coated balloon vs. drug-eluting stent vs. medication for the treatment of de novo coronary bifurcation lesions. Her AY; Kim B; Kim S; Kim YH; Scheller B; Shin ES Eur J Med Res; 2024 May; 29(1):280. PubMed ID: 38735968 [TBL] [Abstract][Full Text] [Related]
3. Effect of Paclitaxel-Coated Balloon Angioplasty on Side Branch Lesion and Cardiovascular Outcomes in Patients with De Novo True Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention. Li Y; Mao Q; Liu H; Zhou D; Zhao J Cardiovasc Drugs Ther; 2022 Oct; 36(5):859-866. PubMed ID: 34241730 [TBL] [Abstract][Full Text] [Related]
4. Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions. Liu H; Tao H; Han X; Lu Y; Xue X; Feng R; Lv F; Liu Y; Jin H; Li L; Gu H J Interv Cardiol; 2022; 2022():8250057. PubMed ID: 35095348 [TBL] [Abstract][Full Text] [Related]
5. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607 [TBL] [Abstract][Full Text] [Related]
6. A novel hybrid strategy of drug coated balloon and stent for coronary bifurcation lesions. Yang H; Song Y; Cao J; Chen J; Zhang F; Huang Z; Qian J; Ge J Scand Cardiovasc J; 2023 Dec; 57(1):2161620. PubMed ID: 36573618 [No Abstract] [Full Text] [Related]
7. Efficacy and safety of drug-coated balloon combined with cutting balloon for side branch of true coronary bifurcation lesions: Study protocol for a multicenter, prospective, randomized controlled trial. Wu H; Deng J; Liang L; Lei X; Yao X; Han W; Chen H; Shou X Front Cardiovasc Med; 2022; 9():1035728. PubMed ID: 36407430 [TBL] [Abstract][Full Text] [Related]
8. Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis. Kim YH; Lee JH; Roh JH; Ahn JM; Yoon SH; Park DW; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Seung KB; Shin WY; Lee NH; Lee BK; Lee SG; Nam CW; Yoon J; Yang JY; Hyon MS; Lee K; Jang JS; Kim HS; Park SW; Park SJ JACC Cardiovasc Interv; 2015 Apr; 8(4):550-60. PubMed ID: 25907082 [TBL] [Abstract][Full Text] [Related]
9. Results From the International Drug Coated Balloon Registry for the Treatment of Bifurcations. Can a Bifurcation Be Treated Without Stents? Bruch L; Zadura M; Waliszewski M; Platonic Z; Eränen J; Scheller B; Götting B; Herberger D; Palmieri C; Sinicròpi G; Motz W J Interv Cardiol; 2016 Aug; 29(4):348-56. PubMed ID: 27242273 [TBL] [Abstract][Full Text] [Related]
10. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions. Yu X; Wang X; Ji F; Zhang W; Yang C; Xu F; Wang F Cardiovasc Drugs Ther; 2022 Aug; 36(4):655-664. PubMed ID: 33713211 [TBL] [Abstract][Full Text] [Related]
11. Impact of kissing balloon inflation on the main vessel stent volume, area, and symmetry after side-branch dilation in patients with coronary bifurcation lesions: a serial volumetric intravascular ultrasound study. Rahman S; Leesar T; Cilingiroglu M; Effat M; Arif I; Helmy T; Leesar MA JACC Cardiovasc Interv; 2013 Sep; 6(9):923-31. PubMed ID: 23954062 [TBL] [Abstract][Full Text] [Related]
12. COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial. Dubois C; Bennett J; Dens J; De Cock D; Desmet W; Belmans A; Ughi GJ; Sinnaeve P; Vrolix M; D'hooge J; Adriaenssens T EuroIntervention; 2016 Apr; 11(13):1457-67. PubMed ID: 25947278 [TBL] [Abstract][Full Text] [Related]
13. Impact of Late Lumen Loss on Clinical Outcomes of Side-Branch Bifurcation Lesions Treated by Drug-Coated Balloon Angioplasty With Main-Branch Stenting. Ikuta A; Kubo S; Ohya M; Tada T; Tanaka H; Fuku Y; Kadota K Cardiovasc Revasc Med; 2022 Aug; 41():92-98. PubMed ID: 34973930 [TBL] [Abstract][Full Text] [Related]
14. Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions: The DKCRUSH-VI Trial (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI). Chen SL; Ye F; Zhang JJ; Xu T; Tian NL; Liu ZZ; Lin S; Shan SJ; Ge Z; You W; Liu YQ; Qian XS; Li F; Yang S; Kwan TW; Xu B; Stone GW JACC Cardiovasc Interv; 2015 Apr; 8(4):536-46. PubMed ID: 25819187 [TBL] [Abstract][Full Text] [Related]
15. DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial. Berland J; Lefèvre T; Brenot P; Fajadet J; Motreff P; Guerin P; Dupouy P; Schandrin C; EuroIntervention; 2015 Dec; 11(8):868-76. PubMed ID: 26696455 [TBL] [Abstract][Full Text] [Related]
16. Angiographic study of the clinical liaison of drug-eluting stent and paclitaxel-eluting balloon in unifocal side branch ostium stenosis (ASCLEPIUS). Jim MH; Wu EB; Chan CY; Wong KL; Fung RC; Yiu KH Heart Vessels; 2017 Sep; 32(9):1045-1050. PubMed ID: 28357514 [TBL] [Abstract][Full Text] [Related]
17. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions. Généreux P; Kumsars I; Lesiak M; Kini A; Fontos G; Slagboom T; Ungi I; Metzger DC; Wykrzykowska JJ; Stella PR; Bartorelli AL; Fearon WF; Lefèvre T; Feldman RL; LaSalle L; Francese DP; Onuma Y; Grundeken MJ; Garcia-Garcia HM; Laak LL; Cutlip DE; Kaplan AV; Serruys PW; Leon MB J Am Coll Cardiol; 2015 Feb; 65(6):533-43. PubMed ID: 25677311 [TBL] [Abstract][Full Text] [Related]
18. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study. Dubois C; Adriaenssens T; Ughi G; Wiyono S; Bennett J; Coosemans M; Ferdinande B; Sinnaeve P; D'hooge J; Desmet W Catheter Cardiovasc Interv; 2013 Feb; 81(3):E155-64. PubMed ID: 22745031 [TBL] [Abstract][Full Text] [Related]
19. Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease. Nishiyama N; Komatsu T; Kuroyanagi T; Fujikake A; Komatsu S; Nakamura H; Yamada K; Nakahara S; Kobayashi S; Taguchi I Int J Cardiol; 2016 Nov; 222():113-118. PubMed ID: 27494722 [TBL] [Abstract][Full Text] [Related]
20. Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three-dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial. Grundeken MJ; Garcia-Garcia HM; Kumsars I; Lesiak M; Kayaert P; Dens J; Stella PR; de Winter RJ; Laak LL; Généreux P; Kaplan AV; Leon MB; Wykrzykowska JJ; Onuma Y; Serruys PW Catheter Cardiovasc Interv; 2017 Feb; 89(2):E53-E63. PubMed ID: 27083384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]